1059 related articles for article (PubMed ID: 25683231)
21. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
22. Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study.
Paillère Martinot ML; Galinowski A; Ringuenet D; Gallarda T; Lefaucheur JP; Bellivier F; Picq C; Bruguière P; Mangin JF; Rivière D; Willer JC; Falissard B; Leboyer M; Olié JP; Artiges E; Martinot JL
Int J Neuropsychopharmacol; 2010 Feb; 13(1):45-59. PubMed ID: 19267956
[TBL] [Abstract][Full Text] [Related]
23. A systematic review and meta-analysis on placebo response to repetitive transcranial magnetic stimulation for depression trials.
Razza LB; Moffa AH; Moreno ML; Carvalho AF; Padberg F; Fregni F; Brunoni AR
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():105-113. PubMed ID: 29111404
[TBL] [Abstract][Full Text] [Related]
24. Blinding integrity in randomized sham-controlled trials of repetitive transcranial magnetic stimulation for major depression: a systematic review and meta-analysis.
Berlim MT; Broadbent HJ; Van den Eynde F
Int J Neuropsychopharmacol; 2013 Jun; 16(5):1173-81. PubMed ID: 23399312
[TBL] [Abstract][Full Text] [Related]
25. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
[TBL] [Abstract][Full Text] [Related]
27. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
[TBL] [Abstract][Full Text] [Related]
28. Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials.
Berlim MT; Van Den Eynde F
Can J Psychiatry; 2014 Sep; 59(9):487-96. PubMed ID: 25565694
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
[TBL] [Abstract][Full Text] [Related]
30. Association of Repetitive Transcranial Magnetic Stimulation Treatment With Subgenual Cingulate Hyperactivity in Patients With Major Depressive Disorder: A Secondary Analysis of a Randomized Clinical Trial.
Hadas I; Sun Y; Lioumis P; Zomorrodi R; Jones B; Voineskos D; Downar J; Fitzgerald PB; Blumberger DM; Daskalakis ZJ
JAMA Netw Open; 2019 Jun; 2(6):e195578. PubMed ID: 31167023
[TBL] [Abstract][Full Text] [Related]
31. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials.
Chen J; Zhou C; Wu B; Wang Y; Li Q; Wei Y; Yang D; Mu J; Zhu D; Zou D; Xie P
Psychiatry Res; 2013 Dec; 210(3):1260-4. PubMed ID: 24113125
[TBL] [Abstract][Full Text] [Related]
32. A systematic review and meta-analysis on the efficacy and acceptability of bilateral repetitive transcranial magnetic stimulation (rTMS) for treating major depression.
Berlim MT; Van den Eynde F; Daskalakis ZJ
Psychol Med; 2013 Nov; 43(11):2245-54. PubMed ID: 23200131
[TBL] [Abstract][Full Text] [Related]
33. Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.
Bretlau LG; Lunde M; Lindberg L; Undén M; Dissing S; Bech P
Pharmacopsychiatry; 2008 Mar; 41(2):41-7. PubMed ID: 18311683
[TBL] [Abstract][Full Text] [Related]
34. The efficacy and safety of low frequency repetitive transcranial magnetic stimulation for treatment-resistant depression: the results from a large multicenter French RCT.
Brunelin J; Jalenques I; Trojak B; Attal J; Szekely D; Gay A; Januel D; Haffen E; Schott-Pethelaz AM; Brault C; ; Poulet E
Brain Stimul; 2014; 7(6):855-63. PubMed ID: 25192980
[TBL] [Abstract][Full Text] [Related]
35. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
[TBL] [Abstract][Full Text] [Related]
36. Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant unipolar depression: A randomized controlled trial (THETA-DEP).
Bulteau S; Laurin A; Pere M; Fayet G; Thomas-Ollivier V; Deschamps T; Auffray-Calvier E; Bukowski N; Vanelle JM; Sébille V; Sauvaget A
Brain Stimul; 2022; 15(3):870-880. PubMed ID: 35609816
[TBL] [Abstract][Full Text] [Related]
37. Two Versus One High-Frequency Repetitive Transcranial Magnetic Stimulation Session per Day for Treatment-Resistant Depression: A Randomized Sham-Controlled Trial.
Theleritis C; Sakkas P; Paparrigopoulos T; Vitoratou S; Tzavara C; Bonaccorso S; Politis A; Soldatos CR; Psarros C
J ECT; 2017 Sep; 33(3):190-197. PubMed ID: 28072660
[TBL] [Abstract][Full Text] [Related]
38. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder.
Carpenter LL; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Stannard EL; Schneider MB
Brain Stimul; 2017; 10(5):926-933. PubMed ID: 28642024
[TBL] [Abstract][Full Text] [Related]
39. [Therapeutic application of repetitive transcranial magnetic stimulation for major depression].
Nakamura M
Seishin Shinkeigaku Zasshi; 2012; 114(11):1231-49. PubMed ID: 23367835
[TBL] [Abstract][Full Text] [Related]
40. Dorsomedial prefrontal cortex repetitive transcranial magnetic stimulation for treatment-refractory major depressive disorder: A three-arm, blinded, randomized controlled trial.
Dunlop K; Sheen J; Schulze L; Fettes P; Mansouri F; Feffer K; Blumberger DM; Daskalakis ZJ; Kennedy SH; Giacobbe P; Woodside B; Downar J
Brain Stimul; 2020; 13(2):337-340. PubMed ID: 31711880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
